Pharma news
Asia-Pacific
Australia-based law firm Piper Alderman has hired Julian Grover as a special counsel in the firm’s intellectual property practice. 10 November 2015
Pharma
The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed. 4 November 2015
Americas
US law firm Baker Donelson has expanded its Memphis office by hiring Cong Ding as of counsel in the firm’s intellectual property group. 30 October 2015
Americas
Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger. 29 October 2015
Pharma
The English High Court has affirmed the validity of the Ono Pharmaceutical’s cancer immunotherapy drug after it was challenged by pharmaceutical company Merck. 29 October 2015
Americas
Oppositions to a patent covering the CRISPR/Cas9 system illustrate the need for applicants to carefully consider making statements on commercially important technology even after a patent application has been filed. Catherine Coombes of law firm HGF reports. 29 October 2015
Americas
The Coalition for Affordable Drugs, an organisation closely tied to hedge fund manager Kyle Bass, has persuaded the Patent Trial and Appeal Board to institute an inter partes review concerning the validity of two patents owned by biopharmaceutical company Celgene. 28 October 2015
Americas
Law firm Duane Morris has hired Paul Li as a partner in the firm’s intellectual property practice in San Francisco. 27 October 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs have tasted success at the Patent Trial and Appeal Board for the second time in a month after it agreed to institute an inter partes review of a patent covering a drug owned by NPS Pharmaceuticals. 27 October 2015
Americas
Lawyers have claimed that the latest ruling in Ariosa Diagnostics v Sequenom creates an “existential threat” to biomedical patents in the US, but is this really the case? LSIPR investigates. 27 October 2015